# Interplay Between Autophagy, Cellular Senescence, and Brain Aging: Neuroprotective Implications of Intermittent Fasting

**Authors:** Ishika Singh, Shreya Bhat, Rajesh Tamatta, Abhishek Kumar Singh

PMC · DOI: 10.1007/s10571-026-01709-7 · 2026-03-11

## TL;DR

This paper explores how intermittent fasting may help protect the brain from aging by boosting autophagy and reducing harmful senescent cells.

## Contribution

The paper highlights the novel interplay between intermittent fasting, autophagy, and cellular senescence in the context of brain aging.

## Key findings

- Intermittent fasting activates autophagy through pathways like AMPK and Sirtuin 1.
- Impaired autophagy contributes to brain aging and neurodegenerative diseases.
- Intermittent fasting may help clear senescent cells and promote brain health.

## Abstract

Aging is characterized by progressive deterioration in cellular function and molecular integrity, which in turn increases vulnerability to age-related diseases, such as neurodegenerative disorders. Cellular senescence is a hallmark of biological aging that plays a crucial role in the development of neurodegenerative diseases. Cellular autophagy, a lysosome-mediated process of degradation, is crucial for maintaining cellular homeostasis and longevity. Nutritional strategies, such as intermittent fasting (IF), which consist of cycles of fasting and normal feeding, have been recognized as potential methods to induce autophagy and derive health benefits. Autophagy is crucial for the degradation of sequestered proteins and damaged organelles, thus maintaining cellular vigor and balance. However, with increasing age, autophagy is compromised, suggesting the need for a stable or optimal rate of autophagy for the maintenance of cellular uptake. IF has the potential to modulate the process of autophagy by inducing changes in ATP and ADP levels during fasting through the activation of pathways such as the AMPK and Sirtuin 1 pathways, which promote the activation of autophagosome formation while simultaneously inhibiting mTOR, an inhibitor of autophagy. Despite the encouraging properties of the IF, there are constraints, as responses may vary incredibly among subjects, and the ideal duration of fasting is uncertain. Furthermore, the potential for new metabolic diseases associated with IF is not fully understood. Understanding the intricate relationships among aging, autophagy, and dietary restrictions such as intermittent fasting could pave the way for novel therapeutic strategies to increase longevity and mitigate age-related health issues.

Brain aging is associated with various hallmarks leading to neurodegenerative diseases and impaired autophagy, causing the accumulation of senescent cells. Intermittent fasting, a dietary regimen, controls food intake by alternating between eating and fasting. It regulates various pathways that facilitate autophagy activation and senescent cells clearance in the brain

## Linked entities

- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), SIRT1 (sirtuin 1), MTOR (mechanistic target of rapamycin kinase)

## Full-text entities

- **Genes:** PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 25747] {aka PPAR}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, ULK1 (unc-51 like autophagy activating kinase 1) [NCBI Gene 8408] {aka ATG1, ATG1A, UNC51, Unc51.1, hATG1}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, Pmp22 (peripheral myelin protein 22) [NCBI Gene 18858] {aka Gas-3, HNPP, PMP-22, TRE002, Tr, trembler}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Rubcn (rubicon autophagy regulator) [NCBI Gene 303885] {aka RGD1305422}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, NEUROG3 (neurogenin 3) [NCBI Gene 50674] {aka Atoh5, Math4B, NGN-3, bHLHa7, ngn3}, Htt (huntingtin) [NCBI Gene 15194] {aka C430023I11Rik, Hd, Hdh, IT15}, Atg7 (autophagy related 7) [NCBI Gene 74244] {aka 1810013K23Rik, Agp7, Apg7l, Atg7l, Gm21553}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, Sirt1 (sirtuin 1) [NCBI Gene 309757] {aka Sir2}
- **Diseases:** white matter lesions (MESH:D056784), tauopathy (MESH:D024801), inflammatory compounds (MESH:D005597), NAFLD (MESH:D065626), obese (MESH:D009765), Age (MESH:D019588), epilepsy (MESH:D004827), alcohol and drug abuse (MESH:D019966), neuroinflammation (MESH:D000090862), cognitive decline (MESH:D003072), Parkinson's disease (MESH:D010300), neurotoxic (MESH:D020258), toxicity (MESH:D064420), cardiovascular disease (MESH:D002318), neurodegenerative (MESH:D019636), HD (MESH:D006816), cytoskeletal abnormalities (MESH:D000014), senescence-accelerated diseases (MESH:D015465), neuronal loss diseases (MESH:D016472), neuropathy (MESH:D009422), cardiomyopathy (MESH:D009202), diabetes (MESH:D003920), Impaired mitochondrial function (MESH:D028361), cerebrovascular dementia (MESH:D003704), metabolic derangement (MESH:D008659), SASP (MESH:D008579), amyloid plaques (MESH:D058225), diminished cerebellar involvement (MESH:D002526), lifestyle disorders (MESH:D009358), cancer (MESH:D009369), sick (MESH:D008881), multiple sclerosis (MESH:D009103), brain-related illnesses (MESH:D001927), overweight (MESH:D050177), tissue dysfunction (MESH:D059226), chronic (MESH:D002908), Proteinopathy (MESH:D057165), AD (MESH:D000544), hypertension (MESH:D006973), caloric deficit (MESH:D009461), hepatic lipid (MESH:D011017), ARDs (MESH:D010024), seizure (MESH:D012640), steatohepatitis (MESH:D005234), inflammation (MESH:D007249), IF (MESH:D007003), degeneration of dopaminergic neurons (MESH:D009410), age-related disorders (MESH:D008569), anxiety (MESH:D001007)
- **Chemicals:** 5xFAD (-), calcium (MESH:D002118), oxygen (MESH:D010100), rapamycin (MESH:D020123), fatty acid (MESH:D005227), ketone bodies (MESH:D007657), lipid (MESH:D008055), glycerol (MESH:D005990), Ketone (MESH:D007659), Triglycerides (MESH:D014280), ADP (MESH:D000244), isoflurane (MESH:D007530), ROS (MESH:D017382), DMSO (MESH:D004121), carbohydrate (MESH:D002241), metformin (MESH:D008687), ATP (MESH:D000255), vitamin D (MESH:D014807), glucose (MESH:D005947), sugar (MESH:D000073893), water (MESH:D014867)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Drosophila melanogaster (fruit fly, species) [taxon 7227], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** YAC128 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_2244), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018527/full.md

---
Source: https://tomesphere.com/paper/PMC13018527